Tazemetostat de(methyl morpholine)-COOH
Modify Date: 2024-04-03 11:48:29
Tazemetostat de(methyl morpholine)-COOH structure
|
Common Name | Tazemetostat de(methyl morpholine)-COOH | ||
|---|---|---|---|---|
| CAS Number | 2685873-44-1 | Molecular Weight | 517.62 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C30H35N3O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Tazemetostat de(methyl morpholine)-COOHTazemetostat de(methyl morpholine)-COOH (compound 7) is a ligand for the PROTAC target protein EZH2, which can be used to synthesis of EZH2 degraders (PROTACs). EZH2 degraders have potent cell viability inhibition in diffuse large B-cell lymphoma (DLBCL) and other subtypes of lymphoma[1]. |
| Name | Tazemetostat de(methyl morpholine)-COOH |
|---|
| Description | Tazemetostat de(methyl morpholine)-COOH (compound 7) is a ligand for the PROTAC target protein EZH2, which can be used to synthesis of EZH2 degraders (PROTACs). EZH2 degraders have potent cell viability inhibition in diffuse large B-cell lymphoma (DLBCL) and other subtypes of lymphoma[1]. |
|---|---|
| Related Catalog |
| Molecular Formula | C30H35N3O5 |
|---|---|
| Molecular Weight | 517.62 |